Join us at the IDC (Influenza Diabetes Community) webinar on Tuesday 16 November, organised in connection with World Diabetes Day 2021 and the theme “Access to Diabetes Care”. The programme features best practice examples on prevention from health care...
Free access to an expert-led, practical and evidence-based tool designed to help you to provide optimal management of type 2 diabetes with glucagon-like peptide-1 receptor agonists (GLP-1RAs). Guided by internationally renowned diabetes researcher Professor Melanie...
Each year PCDE issues a research grant for research projects in Primary Care. The submissions were competitive this year and each of them would have been a worthy winner. The PCDE board would like to thank everyone who submitted a proposal, for their contribution...
EURADIA is undertaking a survey to highlight the impact of the Covid-19 pandemic on research funding. There is already evidence of Diabetes research being impacted – despite an increased threat to health from Covid-19 for people with Diabetes. We are...
Benefits and harms of sodium-glucose co-transporter-2 inhibitors (SGLT2-I) and renin–angiotensin–aldosterone system inhibitors (RAAS-I) versus SGLT2-Is alone in patients with type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials.Samuel...
